Redeye states that the Q2 report was strong in terms of sales but lower than we had estimated.
Analysguiden inleder bevakning av IT-bolaget Qlosr Group med riktkurs 7,20 kronor.
Q2’22 EBIT of SEK 220m vs. ABGSCe SEK 45m Stor-Skälsjön sale the main driver of the beat Still wai...
År 2022 har hittills präglats av ett skifte för SHT Smart High-Tech AB (”SHT” eller ”Bolaget”), från...
Flowscape levererar ytterligare ett starkt kvartal med stigande intäkter och nu står bolagets expans...
Tough Times Ahead, But Plans in Place to Handle Them
Cantargia reported its Q2 numbers for 2022 this morning with an operating loss of SEK -95.
Growth despite postponed projects We reduce sales estimates by 9% for FY’22e The share trades at E...
Redeye considers the Q2 report from Northbaze to be strong and confirm its steps toward becoming a t...
Redeye states that Q2 was OK. While Automotive hasn’t started ramping up yet, management appeared co...
Redeye expected a bit more in terms of top-line growth in Q2, which was softer than we have seen rec...
Slower sales growth than we have become used to We lower long-term EBIT by 5% Lifted COVID-19 rest...
Today (29 August) Ferronordic announced that it has agreed to terminate its dealer agreements with V...
Q2 net sales growth of 16% y-o-y Estimates slightly down after the Q2 report SiteBase is now accre...
Abelco publicerade den 29 augusti 2022 bolagets delårsrapport för andra kvartalet 2022.
Redeye comments on Inhalation Sciences Q2’22 report.
Q2-kommentar Guards kvartalsrapport var i linje med våra förväntningar.
Fortsatt stark organisk tillväxt i Q2 Humble redovisade en nettoomsättning proforma om 1,55 mdkr vil...
Duearity publicerade den 25:e augusti bolagets delårsrapport för årets andra kvartal 2022.
Redeye comments on the Q2 report from Nanexa, which came in more or less as expected.
